Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Sexual affinity

After more than a decade of use, bupropion (24) is considered a safe and effective antidepressant, suitable for use as first-line treatment. In addition, it is approved for smoking cessation and seasonal affective disorder. It is also prescribed off-label to treat the sexual dysfunction induced by SSRIs. Bupropion is often referred to as an atypical antidepressant and has much lower affinity for the monoamine transporters compared with other monoamine reuptake inhibitors. The mechanism of action of bupropion is still uncertain but may be related to inhibition of dopamine and norepinephrine reuptake transporters as a result of active metabolites [71,72]. In a recently reported clinical trial, bupropion extended release (XL) had a sexual tolerability profile significantly better than that of escitalopram with similar re-... [Pg.20]

The following side effects apply to the irreversible, nonselective MAOI antidepressants (phenelzine and tranylcypromine). The most common side effects are orthostatic hypotension, headache, insomnia, weight gain, sexual dysfunction, peripheral edema, and afternoon somnolence. Although MAOIs do not have significant affinity for muscarinic receptors, anticholinergic-like side effects are present at the beginning of treatment. Dry mouth is common but not as marked as in TCA therapy. Fortunately, the more serious side effects, such as hypertensive crisis and serotonin syndrome, are not common. [Pg.53]

Reboxetine. Reboxetine (21) is a norepinephrine-selective reuptake inhibitor that lacks affinity for most of the monoamine receptors. It thus does not exhibit the typical side-effect profile of the tricyclics. Nevertheless, side effects include increased sweating, postural hypotension (leading to dizziness), dry mouth, constipation, blurred vision, impotence, and dysuria. Tachycardia and urinary retention have also been reported (59). There is no evidence of cardiotoxicity and sexual dysfunction seems to be rare. In contrast to some of the earlier tricyclics that are sedative, reboxetine is nonsedating and can cause insomnia (60,61).. [Pg.496]


See other pages where Sexual affinity is mentioned: [Pg.51]    [Pg.51]    [Pg.242]    [Pg.852]    [Pg.102]    [Pg.149]    [Pg.511]    [Pg.46]    [Pg.27]    [Pg.402]    [Pg.515]    [Pg.577]    [Pg.149]    [Pg.147]    [Pg.145]    [Pg.89]    [Pg.157]    [Pg.730]    [Pg.326]    [Pg.247]    [Pg.492]    [Pg.500]    [Pg.145]    [Pg.1242]    [Pg.2258]    [Pg.21]    [Pg.393]    [Pg.234]    [Pg.217]    [Pg.454]    [Pg.176]    [Pg.740]    [Pg.184]    [Pg.421]    [Pg.317]    [Pg.40]    [Pg.54]    [Pg.107]    [Pg.184]    [Pg.217]    [Pg.391]    [Pg.377]   
See also in sourсe #XX -- [ Pg.51 ]




SEARCH



Sexual

Sexuality

© 2024 chempedia.info